Onyx Pharmaceuticals, Inc. (ONXX) Posts Q3 Loss of $0.31, Sales Fall Short
Tweet
Share
E-mailGet Alerts ONXX Hot Sheet
Join SI Premium – FREE
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) reported Q3 EPS of ($0.31), $0.12 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $75.04 million versus the consensus estimate of $80.38 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
